FFRangio System vs QFR

Direct competitors — feature-level head-to-head below. Comparability 95/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CathWorks
VS
by QFR Solutions bv

AI Verdict

Both the CathWorks FFRangio System and QFR by QFR Solutions bv are highly comparable AI-powered tools designed for cardiologists to assess coronary artery disease using X-ray angiographic images. They both provide non-invasive functional assessment (FFRangio vs. QFR) to aid in PCI decision-making, aiming to reduce the need for invasive pressure wires. The choice between them would likely depend on specific feature preferences, integration capabilities, and pricing.

Choose FFRangio System if…

Choose the FFRangio System if your primary goal is a comprehensive, real-time, and entirely non-invasive functional assessment of coronary artery disease across multiple vessels. This tool is ideal for optimizing and confirming PCI decisions, as it eliminates the need for invasive pressure wires, drugs, or guide catheters while providing advanced insights like simulated pullback curves and lesion impact.

View FFRangio System →

Choose QFR if…

Choose QFR if you require an AI-powered solution focused on precise quantitative analysis and visualization of X-ray angiographic images for detailed lesion assessment. This tool excels in automatically detecting vessel contours, performing 3D reconstruction of coronary models, and providing accurate anatomical quantification alongside QFR assessment, enhancing the diagnostic workflow with deep learning capabilities.

View QFR →

When choosing between the CathWorks FFRangio System and QFR by QFR Solutions bv, cardiologists should consider their primary need for real-time, comprehensive functional assessment versus detailed angiographic analysis. The FFRangio System excels at providing wire-free and drug-free 3D FFR guidance, offering real-time FFRangio values across the entire coronary tree and features like a simulated pullback curve and lesion impact assessment. This makes it ideal for quickly optimizing and confirming PCI decisions, particularly for physicians who prioritize immediate, comprehensive functional insights during a procedure.

In contrast, QFR focuses on AI-powered visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images. It offers features like automatic detection and editing of vessel contours, 3D reconstruction of coronary vessel models, and accurate anatomical quantification of lesions. The key practical difference lies in their approach: FFRangio provides a more dynamic, real-time functional assessment without invasive wires, while QFR offers a detailed, AI-enhanced analysis of angiographic images for lesion assessment. Physicians seeking a comprehensive, real-time functional guidance system to streamline PCI decisions may lean towards FFRangio. Those who prioritize in-depth, AI-driven angiographic analysis and anatomical quantification for lesion assessment might find QFR more suitable. Both are deployed on-premise and integrate with cath lab systems.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FFRangio System QFR
Pricing Contact for pricing Contact for quote
Deployment On-premise (integrates with cath lab equipment and C-arm angiography systems) On-premise / Integrated with cath lab systems
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FFRangio System

Tool A explicitly highlights an 'Intuitive user interface' and 'Seamless integration with cath lab boom and PACS' as key features, directly addressing ease of use and workflow. While Tool B lists features that contribute to usability, it does not explicitly state an intuitive interface.

Clinical Value

FFRangio System

Both tools are FDA-cleared and provide FFR/QFR analysis for lesion assessment. However, Tool A offers a broader range of clinical insights, including 'wire-free and drug-free' guidance, 'real-time FFRangio values at every point,' a 'simulated pullback curve,' and a 'Lesion Impact feature,' which collectively suggest a more comprehensive and less invasive approach to optimizing PCI decisions.

Pricing & Value

Tie

Both Tool A and Tool B require direct contact for pricing information, making it impossible to compare their cost or assess their relative value based on publicly available data. Neither tool provides transparent pricing details.

Enterprise Readiness

FFRangio System

Both tools are deployed on-premise and integrate with cath lab systems. However, Tool A explicitly states ISO 27001 certification for information security, which is a strong indicator of robust enterprise-level security and data management practices, providing a higher level of assurance for enterprise deployment.

Innovation

FFRangio System

While both tools leverage AI, Tool A's 'wire-free and drug-free 3D FFR guidance' represents a significant innovation in reducing invasiveness and streamlining the FFR assessment workflow. Its 'real-time FFRangio values at every point' and 'simulated pullback curve' also demonstrate advanced analytical capabilities that push the boundaries of coronary physiology assessment.

Support & Docs

Tie

Neither the provided structured facts nor a general web search revealed specific, publicly available information regarding dedicated support portals, documentation libraries, or service level agreements for either Tool A or Tool B. Therefore, it is not possible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FFRangio System QFR
Name FFRangio System QFR
Company CathWorks QFR Solutions bv
Core Physiological Measurement Wire-free and drug-free 3D FFR guidance, FFRangio values Quantitative Flow Ratio (QFR) analysis
Invasive Component Elimination Eliminates the need for invasive pressure wires, drugs, or a guide catheter Not specified
3D Modeling/Guidance Delivers 3D FFR guidance 3D reconstruction of coronary vessel models
Primary Lesion Assessment Aid Optimize and confirm PCI decisions, Lesion Impact feature to assess residual ischemia, Integrated sizing tool Aiding cardiologists in lesion assessment, Accurate anatomical quantification of lesions, QFR assessment for functional significance
Specific AI Applications Artificial intelligence aids in quick angiogram analysis AI-enabled end-diastolic frame selection, Deep learning for precise alignment of angiographic projections

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and QFR.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing real-time FFRangio values at every point on the coronary tree. In contrast, QFR is an AI-powered medical software that performs quantitative flow ratio (QFR) analysis from X-ray angiographic images, aiding cardiologists in lesion assessment through visualization and calculations in coronary vessel segments.
Both the FFRangio System and QFR are designed for on-premise deployment and integrate with cath lab equipment and C-arm angiography systems. This seamless integration allows for their incorporation into current procedural workflows.
The FFRangio System offers a simulated pullback curve to differentiate functional patterns of CAD, a Lesion Impact feature to assess residual ischemia, and an integrated sizing tool for non-invasive lesion measurements. QFR provides automatic detection and editing of vessel contours, 3D reconstruction of coronary vessel models, and accurate anatomical quantification of lesions.
Yes, the CathWorks FFRangio System explicitly eliminates the need for invasive pressure wires, drugs, or a guide catheter for FFR assessment. Similarly, QFR is a non-invasive, image-based tool that can accurately compute FFR without the need for a pressure wire or hyperemic drug.
The FFRangio System utilizes artificial intelligence to aid in quick angiogram analysis and provide advanced insights for PCI decisions. QFR, on the other hand, leverages AI for specific functions such as AI-enabled end-diastolic frame selection, deep learning for precise alignment of angiographic projections, and automatic detection of vessel contours.
The FFRangio System is ISO 27001 certified for information security, and a Business Associate Agreement (BAA) is likely required as it handles Protected Health Information (PHI). For QFR, HIPAA compliance is unknown, but it is likely compliant given its nature as a medical device handling patient data.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.